CMECalifornia CME/CE Center

Create an Account | Support | Login

SEARCH

Advanced

Username:

Password:

Forgot Password?

Create an Account



	Account
	Curriculum
	Transcript
	Preferences


	Welcome & Mission Statement
	FAQs
	User Technical Support
	Accreditation Legend
	System Requirements


	AAMC CME
	ABMS
	ACCME
	AHRQ
	AMA
	CDC
	MBC



	SGLT2 Inhibitors and CV Outcomes: A Year in Review (Medscape)

Activity Name:	SGLT2 Inhibitors and CV Outcomes: A Year in Review (Medscape)
Activity Information:	This activity is 30 minute video of an expert panel roundtable discussion and is intended for primary care physicians, diabetologists & endocrinologists, cardiologists, and nurses. The goal of this activity is to provide participants with expert perspectives on recent sodium glucose cotransporter-2 (SGLT2) inhibitor-related cardiovascular (CV) outcomes data as well as clinical guidance on how these data should be applied to practice and patient management. A free Medscape account is required to view this content.
Activity URL:	https://www.medscape.org/viewarticle/898991
Credit:	0.50
Credit Unit	Credits
Accreditation:	ACCME - Accreditation Council for Continuing Medical Education > AMA PRA Category 1 Credit
Activity Learning Format:	Internet Activity (Enduring Materials)

Type: Internet Activity (Enduring Material)

9 Registered Users

Credits

0.5 Credits> Accreditation Council for Continuing Medical Education> AMA PRA Category 1 Credit™